Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes
Author(s) -
Ildikò Szabó,
Albrecht LeppleWienhues,
Kristen N. Kaba,
Mario Zoratti,
Erich Gulbins,
Florian Läng
Publication year - 1998
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.95.11.6169
Subject(s) - fas receptor , jurkat cells , tyrosine kinase , microbiology and biotechnology , apoptosis , ceramide , receptor tyrosine kinase , kinase , intracellular , proto oncogene tyrosine protein kinase src , biology , tyrosine , tyrosine kinase inhibitor , signal transduction , programmed cell death , chemistry , biochemistry , t cell , immune system , immunology , cancer , genetics
CD95/Fas/APO-1 mediated apoptosis is an important mechanism in the regulation of the immune response. Here, we show that CD95 receptor triggering activates an outwardly rectifying chloride channel (ORCC) in Jurkat T lymphocytes. Ceramide, a lipid metabolite synthesized upon CD95 receptor triggering, also induces activation of ORCC in cell-attached patch clamp experiments. Activation is mediated by Src-like tyrosine kinases, because it is abolished by the tyrosine kinase inhibitor herbimycin A or by genetic deficiency of p56lck. In vitro incubation of excised patches with purified p56lck results in activation of ORCC, which is partially reversed upon addition of anti-phosphotyrosine antibody. Inhibition of ORCC by four different drugs correlates with a 30-65% inhibition of apoptosis. Intracellular acidification observed upon CD95 triggering is abolished by inhibition of either ORCC or p56lck. The results suggest that tyrosine kinase-mediated activation of ORCC may play a role in CD95-induced cell death in T lymphocytes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom